Literature DB >> 28453405

A meta-analysis of antimicrobial susceptibility profiles for pneumococcal pneumonia in sub-Saharan Africa.

Pui-Ying Iroh Tam1, Ayebo E Sadoh2, Stephen K Obaro2.   

Abstract

BACKGROUND: Pneumonia causes an enormous burden of childhood disease globally, particularly in low- and middle-income countries. Pneumococcus is the most common bacterial aetiology of pneumonia; however, antimicrobials are limited and may not adequately address the local epidemiology of the region. AIM: To undertake a review and meta-analysis of pneumonia studies in sub-Saharan Africa to evaluate antimicrobial susceptibility patterns in childhood pneumonia.
METHODS: Articles published in PubMed and Google between 2006 and 2016 which evaluated antimicrobial susceptibility profiles of pneumococcal pneumonia in children in sub-Saharan Africa were identified. The source of specimens, pathogens and antimicrobial susceptibility data were extracted. Pooled analysis of susceptible isolates was conducted using random effects models.
RESULTS: Children from 15 studies and 1634 isolates were included in the meta-analysis. In cases of childhood pneumonia, the mean overall proportion of penicillin susceptibility from invasive specimens of Streptococcus pneumoniae was 85.7% (95% CI 80.1-91.3), and of trimethoprim-sulfamethoxazole was 21.0% (95% CI 5.1-36.9). Compared with all S. pneumoniae specimens, penicillin susceptibility was 68.6% (95% CI 59.6-77.5) and that of trimethoprim-sulfamethoxazole was 26.3% (95% CI 14.1-38.6).
CONCLUSIONS: A high level of heterogeneity was detected, reflecting the paucity of data available. The establishment of national and regional diagnostic platforms to monitor antimicrobial susceptibility profiles for pneumonia as well as other invasive diseases will provide data with which to assess the relevance and adaptation of antimicrobial prescribing recommendations.

Entities:  

Keywords:  Antimicrobial resistance; clinical trials; diagnostics; lower respiratory tract infection; pneumonia; sub-Saharan Africa; surveillance; susceptibility

Mesh:

Substances:

Year:  2017        PMID: 28453405     DOI: 10.1080/20469047.2017.1298700

Source DB:  PubMed          Journal:  Paediatr Int Child Health        ISSN: 2046-9047            Impact factor:   1.990


  4 in total

1.  Phenotypic and Molecular Characterization of Penicillin and Macrolide-Resistant Streptococcus pneumoniae Serotypes Among Pediatric Patients in Addis Ababa, Ethiopia.

Authors:  Abel Abera Negash; Daniel Asrat; Workeabeba Abebe; Abraham Aseffa; Mario Vaneechoutte
Journal:  Infect Drug Resist       Date:  2021-05-12       Impact factor: 4.003

2.  Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST).

Authors:  Zhijie Zhang; Meng Chen; Ying Yu; Sisi Pan; Yong Liu
Journal:  Infect Drug Resist       Date:  2019-05-10       Impact factor: 4.003

3.  Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study.

Authors:  Pui-Ying Iroh Tam; James Chirombo; Marc Henrion; Laura Newberry; Ivan Mambule; Dean Everett; Charles Mwansambo; Nigel Cunliffe; Neil French; Robert S Heyderman; Naor Bar-Zeev
Journal:  BMJ Open       Date:  2022-02-08       Impact factor: 2.692

4.  Association of Influenza Activity and Environmental Conditions With the Risk of Invasive Pneumococcal Disease.

Authors:  Isha Berry; Ashleigh R Tuite; Angela Salomon; Steven Drews; Anthony D Harris; Todd Hatchette; Caroline Johnson; Jeff Kwong; Jose Lojo; Allison McGeer; Leonard Mermel; Victoria Ng; David N Fisman
Journal:  JAMA Netw Open       Date:  2020-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.